ATM and cellular response to DNA damage

Advances in Experimental Medicine and Biology

Volumn 570, Issue , 2005, Pages 457-476

  Lavin, Martin F ^a,b   Kozlov, Sergei ^a   Gueven, Nuri ^a   Peng, Cheng ^a   Birrell, Geoff ^a   Chen, Phillip ^a   Scott, Shaun ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DOUBLE STRANDED DNA; MRE11 PROTEIN;

ATAXIA; CANCER; CANCER SUSCEPTIBILITY; CELL ACTIVATION; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; DNA DAMAGE; GENOMIC INSTABILITY; HETEROZYGOTE; HUMAN; MOLECULAR SENSOR; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; TELANGIECTASIA;

EID: 34548686800     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/1-4020-3764-3_16     Document Type: Review

References (113)

1. Abraham, R.T. 2001. Cell cycle checkpoint signalling through the ATM and ATR kinases. Genes Dev. 15: 2177-2196.
2. Abraham, R.T. 2004. The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways. DNA Repair. 3: 919-925.
3. Ali, A., J. Zhang, S. Bao, L. Liu, D. Otterness, N.M. Dean, R.T. Abraham, and X.F. Wang. 2004. Requirement of protein phosphatase 5 in DNA damage-induced ATM activation. Genes Dev. 18: 249-254.
4. Athma, P., R. Rappaport, and M. Swift. 1996. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Genet Cytogenet. 92: 130-134.
5. Bache, M., S. Pigorsch, J. Dunst, P. Wurl, A. Meye, F. Bartel, H. Schmidt, F.W. Rath, and H. Taubert. 2001. Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53. Int. J. Cancer. 96: 110-117.
6. Bakkenist, C.J., M.B. Kastan. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421: 499-506.
7. Banin, S., L. Moyal, S. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281: 1674-1677.
8. Beamish, H., M.F. Lavin. 1994. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cycle delay. Int J. Radiat Biol. 65: 175-184.
9. st Inter, Congr of Neurological Sciences, Brussels. London. Pergamon Press. 4: 206.
10. rd, C.A. Bloch, N.T. Perna, V. Burland, M. Riley, J. Collado-Vides, J.D. Glasner, C.K. Rode, G.F. Mayhew, J. Gregor, N.W. Davis, H.A. Kirkpatrick, M.A. Goeden, D.J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science. 277: 1453-1474.
11. Boder, E. 1985. Ataxia-telangiectasia: an overview. In Gatti, R.A., Swift M, eds. Ataxia-Telangiectasia. New York: Alan R Liss, Kroc Foundation Series: 19: 1-63.
12. Boder, E., R.P. Sedgwick. 1957. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report on 7 children, an autopsy, and a case history. Univ S Calif Med Bull. 9: 15-28.
13. Boder, E., R.P. Sedgwick. 1963. Ataxia-telangiectasia. A review of 101 cases. In: Walsh G, ed. Little Club Clinics in Developmental Medicine no.8. London: Heinemann Medical Books. 110-118.
14. Bulavin, D.V., Y. Higashimoto, I.J. Popoff, W.A. Gaarde, V. Basrur, O Potapova, E. Appella, and A.J. Fornace Jr. 2001. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature. 411: 102-107.
15. Canman, C.E., A.C. Wolff, C.Y. Chen, A.J.Jr. Fornace, and M.B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54: 5054-5058.
16. Canman, C.E., D.S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281: 1677-1679.
17. Carbonari, M., M. Cherchi, R. Paganelli, G. Giannini, E. Galli, C Gaetan, C. Papetti, and M. Fiorilli. 1990. Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med. 322: 73-76.
18. rd, L. Hays, W.F. Morgan, and J.H. Petrini. 1998. The hMRE11 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 93: 477-486.
19. Carson, C.T., R.A. Schwartz, T.H. Stracker, C.E. Lilley, D.V. Lee, and M.D. Weitzman. 2003. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22: 6610-6620.
20. Cedervall, B., P. Kallman, and W.C. Dewey. 1995. Repair of DNA double-strand breaks: errors encountered in the determination of half-life times in pulsed-field gel electrophoresis and neutral filter elution. Radiat Res. 142: 23-28.
21. Cerosaletti, K., P. Concannon. 2004. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm.. J. Biol Chem. 279: 38813-38819.
22. Chenevix-Trench, G., A.B. Spurdle, M. Gatei, H. Kelly, A. Marsh, X. Chen, K. Donn, M. Cummings, D. Nyholt, M.A. Jenkins, C. Scott, G.M. Pupo, T. Dork, R. Bendix, J. Kirk, K. Tucker, M.R. McCredie, J.L. Hopper, J. Sambrook., G.J. Mann, and K.K. Khanna. 2002. Dominant negative ATM mutations in breast cancer families. J. Natl. Cancer Inst. 94: 205-215.
23. Cohen, M.M., S.J. Simpson. 1982. The Effect of bleomycin on DNA synthesis in ataxia-telangiectasia lymphoid cells. Environ Mutagen. 4: 27-36.
24. Cornforth, M.W., J.S. Bedford. 1985. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227: 1589-1591.
25. Costanzo, V., K. Robertson, C.Y. Ying, E. Kim, E. Avvedimento, M. Gottesman, D. Grieco, and J. Gautier. 2000. Reconstitution of an ATM-dependent checkpoint that inhibits chromosome DNA replication following DNA damage. Mol Cell. 6: 649-659.
26. Costanzo, V., K. Robertson, and J. Gautier. 2004. Xenopus cell-free extracts to study the DNA damage response. Methods Mol Biol. 280: 213-227.
27. Dalal, S.N., C.M. Schweitzer, J. Gan, and J.A. DeCaprio. 1999. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol. 19: 4465-4479.
28. De Wit, J., N.G.L. Jaspers, and D. Bootsma. 1981. The rate of DNA synthesis in normal and ataxia-telangiectasia cells after exposure to X-irradiation. Mutat Res. 80: 221-226.
29. Dork, T., R. Bendix, M. Bremer, D. Rades, K. Klopper, M. Nicke, B. Skawran, A. Hector, P. Yamini, D. Steinmann, S. Weise, M. Stuhrmann, and J.H. Karstens. 2001. Sprectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 61: 7608-7615.
30. Edwards, M.J., A.M.R. Taylor. 1981. Unusual levels of (ADP-ribose) and DNA synthesis in ataxia-telangiectasia cells following γ-ray irradiation. Nature. 287: 745-747.
31. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumour suppression. Cell. 75: 817-825.
32. Falck, J., N. Mailand, R.G. Syljuasen, J. Bartek, and J. Lukas. 2001. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 410: 842-847.
33. Fitzgerald, M.G., J.M. Bean, S.R. Hedge, H. Unsal, D.J. MacDonald, D.P. Harkin, D.M. Finkelstein, K.J. Isselbacher, and D.A. Haber. 1997. Heterozygous ATM mutations do not contribute to early onset breast cancer. Nature. 15: 307-310.
34. Foray, N., A. Priestly, G. Alsbeith, C. Badie, E.P. Capulas, C.F. Arlett, and E.P. Malaise. 1997. Hypersensitivity of ataxia-telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol. 72: 271-283.
35. Goodarzi, A.A., W.D. Block, and S.P. Lees-Miller. 2003. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog Cell Cycle Res. 5: 393-411.
36. Goodarzi, A.A., J.C. Jonnalagadda, P. Douglas, D. Young, R. Ye, G.B. Moorhead, S.P. Lees-Miller, and K.K. Khanna. 2004. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23: 4451-4461.
37. Goodarzi, A.A., S.P. Lees-Miller. 2004. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. DNA Repair. 3: 753-767.
38. Hamer, G., H.B. Kal, C. H. Westphal, T. Ashley, and D. G. de Rooij. 2004. Ataxia-telangiectasia mutated expression and activation in the Testis. Biology of Reproduction. 70: 1206-1212.
39. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75: 805-816.
40. Hecht, F., R.D. Koler, D.A. Rigas, G.S. Dahnke, M.P. Case, V. Tisdale, and R.W. Miller. 1966. Leukaemia and lymphocytes in ataxia-telangiectasia. Lancet 2: 1193.
41. Hecht, F., B.K. Hecht. 1990. Cancer in ataxia-telangiectasis patients. Cancer Genet Cytogenet. 46: 9-19.
42. Hecht, F., R.D. Koler, D.A. Rigas, G.S. Dahnke, M.P. Case, V. Tisdale, and R.W. Miller. 1966. Leukaemia and lymphocytes in ataxia-telangiectasis. Lancet. 2: 1193.
43. Hecht, F., B.K. McCaw, and R. Koler. 1973. Ataxia-telangiectasia-clonal growth of translocation lymphocytes. N Engl J Med. 289: 286-291.
44. Higurashi, M., P.E. Conen. 1973. In vitro chromosomal radiosensitivity in 'chromosomal breakage syndromes'. Cancer. 32: 380-383.
45. Hirao, A., Y.Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S.J. Elledge, and T.W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287: 1824-1827.
46. Houldsworth, J., M.F. Lavin. 1980. Effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nucleic Acids Res. 8: 3709-3720.
47. Izatt, L., J. Greenman, S. Hodgson, D. Ellis, S. Watt, G. Scott, C. Jacobs, R. Liebmann, M.J. Zvelebil, C. Mathew, and E. Solomon. 1999. Identification of germline missense mutations and rare allelic variants in ATM gene in early-onset breast cancer. Genes Chromosomes Cancer. 26: 286-294.
48. Janin, N., N. Andrieu., K. Ossian, A. Lauge, M.F. Croquette, C. Griscelli, M. Debre, B. Bressac-de-Paillerets, A. Aurias, and D. Stoppa-Lyonett. 1999. Breast cancer risk in ataxia-telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br. J. Cancer. 80: 1042-1045.
49. Jeggo, P., B. Singleton, H. Beamish, and A. Priestley. 1999. Double strand break rejoining by the Ku-dependent mechanism of non-homologous end-joining. CR ACAD Sci III. 322: 109-112.
50. Johnson, R.D., M. Jasin. 2000. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19: 3398-3407.
51. Kastan, M.B., O. Zhan, W.S. EL-Deiry, F Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia. Cell. 71: 587-597.
52. Khanna, K.K. M.F. Lavin. 1993. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene. 8: 3307-3312.
53. Khanna, K.K., H. Beamish, Y. Yan, K. Hobson, R. Williams, I. Dunn, and M.F. Lavin. 1995. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene 17: 609-618.
54. Khanna, K.K., K.E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, S.P. Lees-Miller, and M.F. Lavin. 1998. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet. 20: 398-400.
55. Khosravi, R., R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy. 1999. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96: 14973-14977.
56. Kim, J.S., T.B. Krasieva, V. LaMorte, A.M. Taylor, and K. Yokomori. 2002. Specific recruitment of human cohesin to laser-induced DNA damage. J. Biol. Chem. 277: 45149-45153.
57. Kim, S.T., B. Xu, and M.B. Kastan. 2002. Involvement of the cohesin protein, Smc1, in Atm-dependent independent responses to DNA damage. Genes Dev. 16: 560-570.
58. Kozlov, S., N. Gueven, K. Keating, J. Ramsay, and M.F. Lavin. 2003. ATP activates ataxiatelangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J. Biol Chem. 278: 9309-9317.
59. Larson, G. 1998. An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genetic Testing. 1: 165-170.
60. Lavin, M.F., S. Scott, P. Chen, S. Kozlov, N. Gueven, and G. Birrell. 2003. In Handbook of Cell Signaling vol 3. (Eds. R.A. Bradshaw and E.A. Dennis) Elsevier Science, pp 225-236.
61. Lavin, M.F. 2004. The Mre11 complex and ATM: a two-way functional interaction in recognising and signalling DNA double strand breaks. DNA Repair. 3: 1515-1520.
62. Lavin, M.F., H. Lederman. 2004. Chromosomal Breakage Syndromes associated with immunodeficiency. In: Stiehm E.R. ed. Immunologic Disorders in Infants & Children. 580-605.
63. Lavin, M.F., Y. Shiloh. 1997. The genetic defect in ataxia- telangiectasia. Annu Rev Immunol. 15: 177-202.
64. Lee, J.H. T.T. Paull. 2004. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 304: 93-96.
65. Lehmann, A.R., M.R. James, and S. Stevens. 1982. Miscellaneous observations on DNA repair in ataxia-telangiectasia. In Bridges B A, Harnden D G, eds. A Cellular and Molecular Link with Cancer. New York: John Wiley and Sons. 347-353.
66. Lim, D.S., S.T. Kim, B. Xu, R.S. Maser, J. Lin, J.H. Petrini, and M.B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature. 404: 613-617.
67. Maya, R., M. Balass, S.T. Kim, D. Shkedy, J.F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M.B. Kastan, E. Katzir, and M. Oren. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15: 1067-1077.
68. McFarlin, D.E., W. Strober, and T.A. Waldmann. 1972. Ataxia- telangiectasia. Medicine. 51: 281-314.
69. Meek, K., S. Gupta, D.A. Ramsden, and S.P. Lees-Miller. 2004. The DNA-dependant protein kinase: the director at the end. Immunol Rev. 200: 132-141.
70. Miller, R.W. 1967. Persons with exceptionally high risk of leukaemia. Cancer Res. 27: 2420-2423.
71. Mirzoeva, O.K. J.H. Petrini. 2001. DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol Cell Biol. 21: 281-288.
72. Moore, J.K. J.E. Haber. 1996. Cell cycle and genetic requirements of two pathways of nonhomologous joining repair of double-strand breaks in Saccharomyces cerevisiae. Mol Cell Biol. 16: 2164-2173.
73. Morrell, D., C.L. Chase, L.L. Kupper, and M. Swift. 1986. Diabetes mellitus in ataxiatelangiectasia, Fanconis anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes. 35: 143-147.
74. Morrell, D., C.L. Chase, and M. Swift. 1990. Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet. 50: 119-123.
75. Morris, C., R. Mohamed, and M.F. Lavin. 1983. DNA replication and repair in atxia-telangiectasia cells exposed to bleomycin. Mutat Res. 112: 67-74.
76. Nagasawa, H., J.B. Little. 1983. Comparison of kinetics of X-ray-induced cell killing in normal, ataxia-telangiectasia and hereditary retinoblastoma fibroblasts. Mutat Res. 109: 297-308.
77. Nakanishi, K., T. Taniguchi, V. Ranganathan, H.V New, L.A. Moreau, M. Stotsky, C.G. Mathew, M.B. Kastan, D.T. Waever, and A.D. D'Andrea. 2002. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat, Cell Biol. 4: 913-920.
78. Olsen, J.H., J.M. Hahnemann, A.L. Borresen-Dale, K. Brondum-Nielsen, L. Hammarstrom, R. Kleinerman, H. Kaariainen, T. Lonnqvist, R. Sankila, N. Seersholm, S. Tretli, J. Yuen, J.D. Boice Jr, and M. Tucker. 2001. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J. Natl. cancer Inst. 93: 121-127.
79. Pandita, T.K., W.N. Hittleman. 1992. Initial chromosome damage but not DNA damage is greater in ataxia-telangiectasia cells. Radiat Res. 130: 94-103.
80. Paterson, M.C., P.J. Smith. 1979. Ataxia-telangiectasia, an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet. 13: 291-318.
81. Paull, T.T., M. Gellert. 1998. The 3′ to 5′ exonuclease activity of Mre11 facilitates repair of DNA double strand breaks. Mol Cell. 1: 969-979.
82. Peng, C.Y., P.R. Graves, R.S. Thoma, Z. Wu, A.S. Shaw, and H. Piwnica-Worms. 1997. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on Ser-216. Science. 277: 1501-1505.
83. Peterson, R.D., W.D. Kelly, and R.A. Good. 1964. Ataxia-telangiectasia: its association with a defective thymus, immunological-defective thymus, immunological-deficiency disease, and malignancy. Lancet. 1: 1189-1193.
84. Pfeiffer, P., W. Goedecke, S. Kuhfittig-Kulle, and G. Obe. 2004. Pathways of DNA doublestrand break repair and their impact on the prevention and formation of chromosomal aberrations. Cytogenet Genome Res. 104: 7-13.
85. Powers, J.T., S. Hong, C.N. Mayhew, P.M. Rogers, E.S. Knudsen, and D.G. Johnson. 2004. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res. 2: 203-214.
86. Rary, J.M., M.A. Bender, and T.E. Kelly. 1975. A 14/14 marker chromosome lymphocyte clone in ataxia-telangiectasia. J Hered. 66: 33-35.
87. Saito, H., Y. Minamiya, S. Saito, and J. Ogawa. 2002. Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J. Leuko Biol. 72: 829-836.
88. Savitsky, K., A. Bar-Shira, G. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Fryman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G.J. Jaspers, A.M.R. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins, and Y. Shiloh (1995) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science. 268: 1749-1753.
89. Scott, S.P., R. Bendix, P. Chen, R. Clark, T. Dork, and M.F. Lavin. 2002. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc Natl Acad Sci USA. 99: 925-930.
90. Scott, D. and F. Zampetti-Bosseler. 1982. Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia-telangiectasia fibroblasts. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 42: 679-683.
91. Sedgwick, R.P. and E. Boder (1991) Ataxia-telangiectasia. In Vianney De Jong J.M.B., ed. Hereditary Neuropathies and Spinocerebellar Atrophies. Amsterdam: Elsevier Science, pp 347-423. 1991.
92. Shiloh, Y., E. Tabor, and Y. Becker. 1983. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis. 4: 1317-1322.
93. Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nature Rev Cancer. 3: 155-168.
94. Spector, B.D., A.H. Filipovich, G.S.III. Perry, and J.H. Kersey. 1982. Epidemiology of cancer in ataxia-telangiectasia. In Bridges B A, Harnden D G, eds. Ataxia-Telangiectasia. Chichester: Wiley. 103-138.
95. Stewart, G.S., R.S. Maser, T. Stankovic, D.A. Bressan, M.I. Kaplan, N.G. Jaspers, A. Raams, P.J. Byrd, J.H. Petrini, and A.M. Taylor. 1999. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99: 577-587.
96. Stewart, G.S., J.I. Last, T. Stankovic, N. Haites, A.M. Kidd, P.J. Bryd, and A.M.Taylor. 2001. Residual ataxia-telangiectasia mutated protein function in cells from ataxia-telangiectasia patients, with 5762ins 137 and 7271T >G mutations showing a less severe phenotype. J. Biol Chem. 276: 30133-30141.
97. Stracker, T.H., J.W. Theunissen, M. Morales, and J.H. Petrini. 2004. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair (Amst). 3: 845-854.
98. Swift, M., D. Morrell, R.B. Massey, and C.L. Chase. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Eng J Med. 325: 1831-1836.
99. Taylor, A.M.R. 1982. Cytogenetics of ataxia-telangiectasia. In bridges B A, Harnden D G, eds. Ataxia-Telangiectasia-A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency. New York: Wiley. 53-83.
100. Taylor, A.M., D.G. Harnden, C.F. Arlett, S.A. Harcourt, A.R. Lehmann, S. Stevens, and B.A. Bridges. 1975. Ataxia-Telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 4: 427-429.
101. Taylor A.M., J.R. Matcalfe, J.M. Oxford, and D.G. Harnden. 1976. Is chromatid-type damage in ataxia-telangiectasia after irradiation at G0 a consequence of defective repair? Nature. 260: 441-443.
102. Teraoka, S.N., K.E. Malone, D.R. Doody, N.M. Suter, E.A. Ostrander, J.R. Daling, and P. Concannon 2001. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. 92: 479-487.
103. Thompson, T., C. Tovar, H. Yang, D. Carvajal, B.T. Vu, Q. Xu, G.M. Wahl, D.C. Heimbrook, and L.T. Vassilev. 2004. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol Chem. (October 6, published ahead of print).
104. Trujillo, K.M., S.S. Yuan, E.Y. Lee, and P. Sung. 1998. Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11 and p95. J. Biol Chem. 273: 21447-21450.
105. Uziel, T., Y. Lerenthal, L. Moyal, Y. Andegeko, L. Mittelman, and L. Shiloh. 2003. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22: 5612-5621.
106. Waldmann T.A. Immunological abnormalities in ataxia-telangiectasia. 1982. In Bridges B A, Harden D G, eds. Ataxia-Telaniectasia: A Cellular and Molecular Link Between Cancer Neuropathology and Immune Deficiency. New York: Wiley. 37-51.
107. Wang, Y., D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, and J. Qin. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14: 927-939.
108. Wang, B., S. Matsuoka, P.B. Carpenter, and S.J. Elledge. 2002. 53BP1, a mediator of the DNA damage checkpoint. Science. 298: 1435-1438.
109. Xu, B., S.T. Kim, and M.B. Kastan. 2001. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol. 21: 3445-3450.
110. Xu, B. S. T. Kim, D.S. Lim, and M.B. Kastan. 2002. Two molecularly distinct g(2)/m checkpoints are induced by ionizing irradiation. Mol. Cell Biol. 22: 1049-1059.
111. Zacchi, P., M. Gostissa, T. Uchida, C. Salvagno, F. Avolio, S. Volinia, Z. Ronai, G. Blandino, C. Schneider, and G. Del Sal. 2002. The prolyl isomerase Pin1 reveals a mechanism to control p5 functions after genotoxic insults. Nature. 419: 853-857.
112. Yazdi, P.T., Y. Wang, S. Zhao, N. Patel, E.Y. Lee, and J. Qin. 2002. SMC1 is a downstream effector in the ATM/NBS1 branch of the human phase checkpoint. Genes Dev. 16: 571-582.
113. Zampetti-Besseler, F. and D. Scott. 1981. Cell death, chromosome damage and mitotic delay in normal human, ataxia-telangiectasia and retinoblastoma fibroblasts after x-irradiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 39: 547-558.